Clinical Trials

90 enrolled

Phase 1 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07316686 2026-05-18

Lutécio

18 enrolled

Phase 1/2 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07590934 2026-05-15

PROSPECTOR

152 enrolled

Prostatic Neoplasms

NCT07524257 2026-05-04

Phase 3 Study of Nogapendekin Alfa Inbakicept Plus Standard of Care vs Standard of Care in First-Line Advanced or Metastatic NSCLC

494 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07566052 2026-05-04

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

356 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07545044 2026-04-22

A Study of JSKN003 Versus Trastuzumab in Combination With Pertuzumab and Docetaxel as First-Line Treatment for HER2-Positive Recurrent or Metastatic Breast Cancer

60 enrolled

Breast Neoplasms

NCT07527806 2026-04-17

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

156 enrolled

Breast Neoplasms

NCT07518147 2026-04-08

A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment

438 enrolled

Stomach Neoplasms

NCT07518173 2026-04-08

A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and Pertuzumab in Patients With First-line HER2-positive Recurrent or Metastatic Breast Cancer

596 enrolled

HER2-positive Breast Cancer

NCT07432178 2026-04-02

CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）

2,288 enrolled

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

596 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07464327 2026-03-11

A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations

450 enrolled

Phase 2/3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07459751 2026-03-10

A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

671 enrolled

Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

NCT07442565 2026-03-04

SYNSTAR03

506 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07423611 2026-02-20

RACE

388 enrolled

Breast Neoplasms

NCT07416994 2026-02-18

Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung Cancer

440 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07214987 2026-01-30

PDT For Induction Therapy For Head And Neck Cancer

26 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT07371897 2026-01-28

SHINE

154 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07361484 2026-01-23

Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)

442 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07354984 2026-01-21

PIONEER-HN

Squamous Cell Carcinoma of Head and Neck

NCT07333066 2026-01-12

REINFORCE

320 enrolled

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT06724042 2025-12-10

Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors

159 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07268794 2025-12-08

CONVERT-HB1

112 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07246317 2025-11-28

Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer

188 enrolled

Breast Neoplasms

NCT07242274 2025-11-21

Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC

472 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07136974 2025-08-22

Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.

280 enrolled

Breast Neoplasms

NCT07116824 2025-08-12

HB1801 Combined Treatment of HER2-positive Breast Cancer

80 enrolled

Phase 4 Not yet recruiting

HER2-positive Breast Cancer

NCT07093931 2025-07-30

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

468 enrolled

Breast Neoplasms

NCT07083505 2025-07-24

A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast Cancer

60 enrolled

Advanced Breast Cancer

NCT06996093 2025-05-30

Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor

2,508 enrolled

Breast Neoplasms

NCT06861712 2025-04-25

Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer

50 enrolled

Phase 1 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck

NCT06925659 2025-04-17

A Study of QLM2011 in Subjects With Advanced Solid Tumors

172 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06914687 2025-04-06

Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Esophageal Neoplasms, Stomach Neoplasms

NCT06895369 2025-03-26

The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC

Squamous Cell Carcinoma of Head and Neck

NCT06892431 2025-03-25

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

150 enrolled

Nasopharyngeal Neoplasms, Recurrence

NCT06795503 2025-01-28

Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients

1,462 enrolled

Triple Negative Breast Neoplasms

NCT06775483 2025-01-15

Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study

220 enrolled

Advanced Non-small Cell Lung Cancer

NCT06745193 2024-12-20

A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer

63 enrolled

Advanced Esophageal Carcinoma

NCT06713057 2024-12-03

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

20 enrolled

Thyroid Neoplasms

NCT06684054 2024-11-12

STFREiYTNBC

Not yet recruiting

Breast Neoplasms

NCT06525350 2024-07-29

A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung Cancer

256 enrolled

Recurrence

NCT06492941 2024-07-09

A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer

142 enrolled

Advanced Pancreatic Cancer

NCT06470633 2024-06-24

To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer

29 enrolled

Breast Neoplasms

NCT06430411 2024-05-28

OLIGOMET

Not yet recruiting

500 enrolled

Prostatic Neoplasms

NCT06411171 2024-05-17

Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer:

36 enrolled

Phase 1/2 Not yet recruiting

Gastroesophageal Junction Cancer

NCT06394713 2024-05-01

A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors

60 enrolled

Other neoplasm

Advanced Malignant Neoplasm

NCT06360978 2024-04-11

Efficacy and Toxicity of Docetaxel as a Radiosenstizer in Head and Neck Cancer

Phase 2/3 Not yet recruiting

Head and Neck Neoplasms

NCT06319313 2024-03-20

Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer

534 enrolled

Squamous Cell Non-small Cell Lung Cancer

NCT06227065 2024-01-26

POLO

28 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05910034 2023-06-18

Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC

132 enrolled